TÜBINGEN, Germany, Aug. 23, 2023 /PRNewswire/ — Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29…